Status:
UNKNOWN
The Clinical Feasibilityof a Multi-modal Photoacoustic/Ultrasonic Imaging System in Rheumatoid Arthritis
Lead Sponsor:
Peking Union Medical College Hospital
Conditions:
Rheumatoid Arthritis
Ultrasonography
Eligibility:
All Genders
Brief Summary
New type of imaging method is in demand clinically for early detection and treatment guiding of RA. Photoacoustic imaging (PAI), a hot spot in medical imaging society, which combines the merits of opt...
Detailed Description
The multi-modal PA/US imaging system was built on a high-end commercial US platform, and allowed real-time imaging of grey-scale US imaging, Color-Doppler US (CDUS) imaging and dual-wavelength PA imag...
Eligibility Criteria
Inclusion
- The inclusion criteria
- The patients were above 18 years-old;
- The patients were diagnosed with RA according to the American College of Rheumatology (ACR) criteria, and the current clinical state was in-active or relapse;
- The patients were consent to receive examinations of photoacoustic imaging.
- The exclusion criteria
- The patients had mental disease or other severe diseases, and were not capable of receiving imaging examinations;
- The patients had strong reaction to laser light.
Exclusion
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04297475
Start Date
January 1 2019
End Date
December 31 2022
Last Update
October 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China, 100730